Press Releases :: Moleculin Biotech, Inc. (MBRX)

Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial

Apr 4, 2018

Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2017

Mar 28, 2018

Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials

Mar 27, 2018

Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery

Mar 20, 2018

Moleculin to Present at the 30th Annual ROTH Conference Tuesday, March 13, 2018

Mar 6, 2018

Reminder: Moleculin Announces Conference Call to Discuss Recent Discovery of New Molecule and Business Update on Wednesday, February 28, 2018

Feb 28, 2018

Moleculin Announces Conference Call to Discuss Recent Discovery of New Molecule and Business Update on Wednesday, February 28, 2018

Feb 22, 2018

Moleculin Announces Pricing of $9 Million Registered Direct Offering

Feb 16, 2018

Moleculin Announces Breakthrough Discovery of a New Molecule for Cancer Treatment

Feb 15, 2018

Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer

Feb 13, 2018